Elvina Almuradova: Metastasis-free or treatment-free survival

Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X about a recent paper titled “Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial” published in Journal of Clinical Oncology.

Authors: David J. Einstein, Meredith M. Regan, Julia S. Stevens, David F. McDermott and Ravi A. Madan.

“Metastasis-free or treatment-free survival?

The EMBARK trial raises tough questions for prostate cancer care.

Which would you choose?

Is the trade-off worth it?”

Source: Elvina Almuradova/X